Trials / Recruiting
RecruitingNCT06346093
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
A Prospective, Randomised Placebo Controlled Trial of Faecal Microbiota Transplantation in Patients With Advanced Gastric Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 124 (estimated)
- Sponsor
- Changhai Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a randomized, double-blind and placebo-controlled study. The purpose of this study is to evaluate the efficacy and safety of FMT capsules combined with chemotherapy and anti-PD1/PDL1 therapy in the advanced gastric cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Fecal Microbiota Transplantation Capsules | FMT Capsules in Combination with Chemotherapy and Anti-PD1/PD-L1 Therapy |
| PROCEDURE | Placebo | Mainly composed of starch, the appearance, shape, color, and size are exactly the same as FMT capsules |
Timeline
- Start date
- 2024-04-02
- Primary completion
- 2030-06-30
- Completion
- 2030-06-30
- First posted
- 2024-04-03
- Last updated
- 2025-06-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06346093. Inclusion in this directory is not an endorsement.